BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25414482)

  • 1. A right-sided subcutaneous implantable cardioverter defibrillator in a patient with congenital heart disease.
    Waller JR; Salmon AP; Roberts PR
    Europace; 2015 Jan; 17(1):77. PubMed ID: 25414482
    [No Abstract]   [Full Text] [Related]  

  • 2. A shock lead intentionally placed in the left ventricle.
    Kraaier K; Verhorst PM; Scholten MF
    Pacing Clin Electrophysiol; 2009 May; 32(5):675-6. PubMed ID: 19422593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardioverter-defibrillator implantation in a patient with persistent left superior vena cava--a case report].
    Kempa M; Lubiński A; Wilczek R; Królak T; Pazdyga A; Raczak G
    Kardiol Pol; 2006 Nov; 64(11):1281-3. PubMed ID: 17165164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Technique for Surgical Epicardial Implantation of a Cardioverter-Defibrillator in Children and Adults With Congenital Heart Disease.
    Pospiech T; Roubertie F; Jalal Z; Bordachar P; Thambo JB
    Ann Thorac Surg; 2016 Aug; 102(2):615-9. PubMed ID: 27207391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter-defibrillator insertion in congenital heart disease without transvenous access to the heart.
    Nery PB; Green MS; Khairy P; Alhebaishi Y; Hendry P; Birnie DH
    Can J Cardiol; 2013 Feb; 29(2):254.e1-3. PubMed ID: 22749646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% should undergo prophylactic implantation of an implantable cardioverter defibrillator.
    Silka MJ; Bar-Cohen Y
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):298-306. PubMed ID: 19808422
    [No Abstract]   [Full Text] [Related]  

  • 7. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease.
    Triedman JK
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):307-16; discussion 316. PubMed ID: 19808423
    [No Abstract]   [Full Text] [Related]  

  • 8. A completely subcutaneous implantable cardioverter defibrillator in a patient with situs inversus totalis.
    van Opstal JM; Blaauw Y; Pison LP
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):333. PubMed ID: 21539637
    [No Abstract]   [Full Text] [Related]  

  • 9. Multi-modality imaging in an exceptional case of aborted sudden cardiac death.
    Sonck J; Tanaka K; Czapla J; Vanderhasselt T; Kayaert P; Scott B; Sutherland G; Van Camp G
    Int J Cardiol; 2014 Feb; 171(2):e57-8. PubMed ID: 24365616
    [No Abstract]   [Full Text] [Related]  

  • 10. Totally subcutaneous implantable cardioverter-defibrillator in a child with complex congenital heart disease and infection in a previous transvenous system.
    García-Riesco L; Pedrote A; Arana-Rueda E; Adsuar A; Arce-León Á; Guerrero-Márquez F
    Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):961-2. PubMed ID: 25239180
    [No Abstract]   [Full Text] [Related]  

  • 11. A patient with congenital heart disease and ventricular tachycardia: what is the course of the device lead?
    Kanter RJ; Darden WB; Herlong JR; Barker PC; Jaggers J
    Pacing Clin Electrophysiol; 2007 Nov; 30(11):1401-3. PubMed ID: 17976107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocautery-induced ventricular fibrillation during routine implantable cardioverter-defibrillator generator replacement.
    Cassagneau R; Hanninen M; Yee R
    Europace; 2014 Mar; 16(3):319. PubMed ID: 24068449
    [No Abstract]   [Full Text] [Related]  

  • 13. Transvenous cardioverter-defibrillator implantation with a double coil lead via persistent left superior vena cava.
    Paperini L; Pardini E; Ebert AG; Galli M
    Ital Heart J; 2004 Sep; 5(9):711-3. PubMed ID: 15568602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nontransvenous implantable cardioverter defibrillator systems: not just for small pediatric patients.
    Kugler JD; Erickson CC
    J Cardiovasc Electrophysiol; 2006 Jan; 17(1):47-8. PubMed ID: 16426399
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective left ventricular sensing lead implantation to overcome undersensing of ventricular fibrillation during implantable cardioverter defibrillator implantation.
    Steinberg C; Philippon F; O'Hara G; Molin F
    Can J Cardiol; 2013 Jun; 29(6):751.e3-6. PubMed ID: 23395280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantation of the right ventricular lead of an implantable cardioverter-defibrillator complicated by apical myocardial infarction.
    Nishiyama N; Takatsuki S; Kimura T; Aizawa Y; Fukumoto K; Hagiwara Y; Tanimoto K; Fukuda K
    Circulation; 2012 Sep; 126(10):1314-5. PubMed ID: 22949541
    [No Abstract]   [Full Text] [Related]  

  • 17. Congenital Left Ventricular Diverticulum Complicated by Ventricular Fibrillation.
    Yamasaki M; Kawamatsu N; Yoshino K; Abe K; Misumi H
    Ann Thorac Surg; 2017 Sep; 104(3):e271-e273. PubMed ID: 28838526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Extrapericardial Minimally Invasive Approach for Implantable Cardioverter Defibrillator.
    Madjarov JM; Katz MG; Poole B; Madzharov S; Fedor JM; Robicsek F
    Thorac Cardiovasc Surg; 2017 Sep; 65(6):475-478. PubMed ID: 28324909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implant and clinical characteristics for pediatric and congenital heart patients in the national cardiovascular data registry implantable cardioverter defibrillator registry.
    Jordan CP; Freedenberg V; Wang Y; Curtis JP; Gleva MJ; Berul CI
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1092-100. PubMed ID: 25287482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter Experience of Subcutaneous Implantable Cardioverter-Defibrillator Therapy in Patients With Dextrocardia.
    Lüker J; Padala SK; Cano Ó; Beiert T; Osswald B; Koneru JN; Schrickel JW; Kron J; Franqui-Rivera H; Gonzalez-Cordero A; Al-Ghamdi BS; Roberts PR; Ceresnak SR; von Alvensleben J; Sultan A; Steven D
    JACC Clin Electrophysiol; 2019 Oct; 5(10):1226-1228. PubMed ID: 31648749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.